SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2009-01-12
Filing Date Changed: 2009-01-21
Documents: 4
SEC Accession No.
0000812796-09-000004
Filing date: 2009-01-21
Accepted: 2009-01-21 17:00:15
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K pipe0120098k.htm 32899 8K FOR PIPE OF JAN 2009 DOR
2 EX-10.1 securitiespurchaseagreement.htm 190475 SECURITIES PURCHASE AGREEMENT
3 EX-10.2 formofwarrant.htm 79346 FORM OF WARRANT
4 EX-10.3 registrationrightsagreement.htm 160785 REGISTRATION RIGHTS AGREEMENT
0000812796-09-000004.txt 465285 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09537099
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628